Numans: 2530 discloseable transaction acquisition of listed securities

Wednesday, Mar 4, 2026 6:02 am ET1min read

Numans: 2530 discloseable transaction acquisition of listed securities

Numans Health Food (02530) Discloses Multiple Acquisitions of Listed Securities in Recent Months

Numans Health Food Holdings Company Limited (02530) has disclosed several transactions involving the acquisition of listed securities in early 2026, according to regulatory filings and news reports. These purchases include shares in technology and pharmaceutical firms, reflecting the company's strategic investments in growth-oriented sectors.

Between January 23 and February 5, 2026, Numans acquired a total of 6 million shares of Lenovo Group for approximately HK$53 millionaccording to filings. Additionally, the company purchased 3 million shares of XtalPi (2228.HK) for HK$33.8 million on February 5, following earlier acquisitions of 2 million and 3.5 million XtalPi shares in late January for HK$25.7 million and HK$43.1 million, respectively as reported. These transactions highlight Numans' focus on diversifying its investment portfolio, with XtalPi—a developer of AI-driven drug discovery platforms—being a recurring target.

Separately, Numans announced a change in its independent auditor, appointing Fuliroumaze after the resignation of its prior auditor. The company stated that this transition may lead to a delay in the release of its 2025 annual resultsaccording to company announcements. While no specific timeline was provided, the firm emphasized it is implementing measures to address the delay and ensure compliance with regulatory requirements.

The disclosed transactions align with Numans' broader strategy to allocate capital toward high-growth equities, though investors may monitor the auditor transition's impact on transparency and reporting timelines. As of March 4, 2026, Numans' stock (2530.HK) has shown volatility, with analysts noting mixed sentiment regarding its fundamental performance according to market analysis.

Investors are advised to review the company's ongoing disclosures for updates on both its investment activities and financial reporting progress.

(https://www.itiger.com/stock/02530/news): Source: hkexnews.hk, reuters.com, and itiger.com news filings.

Numans: 2530 discloseable transaction acquisition of listed securities

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet